StockData
Rocket Pharmaceuticals, Inc. logo

Rocket Pharmaceuticals, Inc. (RCKT) shareholders

RCKTNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 3/30
$2.11+0.00 (0.00%)

Close on Nov 18, 2026Market cap $231.62MP/E –Yield –

Ownership

Institutional holdings as of Jun 30, 2026, from 13F filings

Held by institutions
90.9%
100M of 110M shares
Institutional holders
180
18 new, 33 sold out
Net institutional buying
3M
In Q2 2026
Insider trades, 12 months
1 buys · 25 sales
Net sold $950.32K

Shares held by institutions

Holders of more than 5%

Latest Schedule 13D (active) or 13G (passive) filed by each holder

HolderShares% of classFilingAs of
Roderick Wong, M.D
Joint filing with RTW Investments, LP (17.40%)
18,401,31317.60%13D (active) amendmentDec 12, 2024
Wellington Management Company LLP
Joint filing with Wellington Management Group LLP (13.40%), Wellington Group Holdings LLP (13.40%) and 1 more
13,995,17712.90%13G (passive) amendmentDec 31, 2024
Wellington Group Holdings LLP
Joint filing with Wellington Management Group LLP (11.80%), Wellington Investment Advisors Holdings LLP (11.80%) and 1 more
12,626,49111.80%13G (passive) amendmentMar 31, 2025
Lee S. Ainslie III
Joint filing with Maverick Capital, Ltd. (7.80%), Maverick Capital Management, LLC (7.80%)
8,363,8137.80%13G (passive) amendmentJun 30, 2025
Wellington Management Group LLP
Joint filing with Wellington Group Holdings LLP (6.70%), Wellington Investment Advisors Holdings LLP (6.70%) and 1 more
7,151,7216.70%13G (passive) amendmentApr 30, 2025
BlackRock, Inc.5,930,1786.60%13G (passive) amendmentDec 31, 2023

Top institutional holders

13F holdings as of Jun 30, 2026

HolderShares% of RCKTValueChange% of portfolio
Rtw Investments, LP17,687,77216.11%$60.49M–0.52%
BlackRock, Inc.9,923,9629.04%$33.94M+2,089,1670.00%
Vanguard Portfolio Management LLC5,810,0335.29%$19.87M+1,119,8180.00%
Citigroup Inc4,865,5514.43%$16.64M−242,1570.01%
Marshall Wace, Llp4,029,2623.67%$13.78M+990,5470.01%
Millennium Management LLC4,000,3443.64%$13.68M+882,2200.00%
Newtyn Management, LLC4,000,0003.64%$13.68M+834,1001.71%
Maverick Capital Ltd3,923,9633.57%$13.42M+356,5910.12%
Vanguard Capital Management LLC3,784,3873.45%$12.94M+8,6510.00%
Aqr Capital Management LLC3,386,1623.08%$11.58M+316,2320.00%
Goldman Sachs Group Inc2,833,4272.58%$9.69M+1,112,3110.00%
Monaco Asset Management SAM2,480,4682.26%$8.48M+422,1650.67%
Geode Capital Management, LLC2,370,7292.16%$8.11M+181,4730.00%
Federated Hermes, Inc.2,304,2072.10%$7.88M+1,280,4600.01%
JPMorgan Chase & Co1,988,4131.81%$6.70M+1,192,1890.00%
Jacobs Levy Equity Management, Inc1,974,8961.80%$6.75M+1,558,3630.02%
State Street Corp1,820,1211.66%$6.22M−2,665,8680.00%
Dimensional Fund Advisors LP1,125,5001.03%$3.85M+837,2360.00%
Morgan Stanley1,062,5220.97%$3.63M−957,5860.00%
Opaleye Management Inc.1,000,0000.91%$3.42M+45,0000.31%

Institutional buying and selling by quarter

Positions opened, added to, reduced and closed by 13F filers

QuarterHoldersShares held% of sharesNew / addedReduced / closedShares boughtShares sold
Q2 2026180100M90.9%18 / 7265 / 3318M15M
Q1 202619997M88.5%48 / 8053 / 3231M17M
Q4 202518691M83.2%31 / 6171 / 1814M21M
Q3 202517399M89.9%28 / 6063 / 5016M13M
Q2 202519695M87.0%41 / 8048 / 8027M39M
Q1 2025236108M98.2%49 / 11241 / 3512M14M
Q4 2024225110M99.9%59 / 9744 / 2526M10M
Q3 202419293M85.0%34 / 6653 / 1914M7M
Q2 202417892M84.0%21 / 7550 / 276M9M
Q1 202418594M86.0%19 / 6962 / 279M4M
Q4 202319490M82.3%37 / 6964 / 178M7M
Q3 202317589M81.4%29 / 7945 / 1717M5M

Top mutual fund and ETF holders

Latest monthly portfolio reports (Form N-PORT)

159 funds held RCKT in Q2 2026, 43% of their shares through ETFs. Each fund counts once per quarter, from its quarter-end report.

FundShares% of RCKTValue% of fundAs of
Vanguard Total Stock Market Index Fund2,700,2882.46%$9.23M0.00%Jun 30, 2026
iShares Russell 2000 ETF2,372,1042.16%$8.11M0.01%Jun 30, 2026
Vanguard Strategic Equity Fund1,696,7611.55%$5.80M0.05%Jun 30, 2026
Federated Hermes MDT Small Cap Core Fund1,037,9710.95%$3.23M0.14%Jul 31, 2026
Vanguard Strategic Small-Cap Equity Fund1,005,3250.92%$3.44M0.11%Jun 30, 2026
Vanguard Extended Market Index Fund1,000,8680.91%$3.42M0.00%Jun 30, 2026
Fidelity Small Cap Index Fund984,9360.90%$3.06M0.01%Jul 31, 2026
iShares Russell 2000 Value ETF844,9090.77%$2.89M0.02%Jun 30, 2026
iShares Biotechnology ETF730,4020.67%$2.50M0.03%Jun 30, 2026
Bridge Builder Small/Mid Cap Growth Fund728,7840.66%$2.49M0.02%Jun 30, 2026
Vanguard Explorer Fund618,5170.56%$1.92M0.01%Jul 31, 2026
Fidelity Extended Market Index Fund461,6140.42%$1.42M0.00%May 31, 2026
Fidelity Enhanced Small Cap Core ETF459,9020.42%$1.57M0.03%Jun 30, 2026
Vanguard Russell 2000 Index Fund435,4830.40%$1.34M0.01%May 31, 2026
Federated Hermes MDT Small Cap Growth Fund432,5670.39%$1.35M0.16%Jul 31, 2026

Officers, directors and major owners

People who filed Forms 3, 4 or 5 in the last two years

NameRoleShares owned% of sharesLatest filing
Martin WilsonGeneral Counsel541,0130.49%Nov 17, 2026
Gaurav ShahCEO1,459,8121.33%Nov 17, 2026
Sarbani ChaudhuriSee Remarks257,9370.23%Nov 12, 2026
Christopher James StevensChief Operating Officer505,7840.46%Aug 13, 2026
Joseph ManhedePrincipal Accounting Officer52,5760.05%Jul 8, 2026
John MilitelloSee Remarks89,7800.08%May 28, 2026
Syed Ali-aamir RizviChief Medical Officer407,8740.37%Feb 13, 2026
Jonathan David SchwartzSee Remarks299,0640.27%Nov 20, 2025
Aaron OndreyChief Financial Officer128,1730.12%Jul 8, 2025
Kinnari PatelSee Remarks573,6280.52%May 22, 2025
David P. SouthwellDirector317,6460.29%Aug 5, 2026
Roderick WongDirector, 10% owner18,263,95616.64%Jul 6, 2026
Fady Ibraham MalikDirector52,8620.05%Jul 6, 2026
Mikael DolstenDirector67,0820.06%Jul 6, 2026
Peter FongDirector76,1950.07%Jul 6, 2026
Carsten BoessDirector52,8620.05%Jul 6, 2026
Elisabeth BjorkDirector50,0000.05%Jan 6, 2026
Rtw Investments, LpDirector, 10% owner18,295,12416.67%Sep 23, 2025
Gotham MakkerDirector1,017,4120.93%Jul 18, 2025
Pedro P. GranadilloDirector54,7340.05%Jul 18, 2025
Piratip PratumsuwanDirector30,0000.03%Jul 18, 2025

Insider trades

Common stock transactions reported on Form 4, newest first

InsiderDateTransactionSharesPriceValueShares after
Gaurav Shah
CEO
Nov 13, 2026Sale−3,020$2.25$6.80K1,053,574
Martin Wilson
General Counsel
Nov 13, 2026Sale−4,087$2.25$9.20K541,013
Sarbani Chaudhuri
See Remarks
Nov 9, 2026Sale−4,872$2.33$11.34K257,937
Martin Wilson
General Counsel
Nov 5, 2026Sale−53,389$2.39$127.81K545,100
Martin Wilson
General Counsel
Sep 11, 2026Sale−75,364$3.40$256.24K598,489
Gaurav Shah
CEO
Aug 18, 2026Sale−2,293$3.38$7.75K1,056,594
Martin Wilson
General Counsel
Aug 18, 2026Sale−631$3.38$2.13K673,853
Martin Wilson
General Counsel
Aug 13, 2026Sale−3,493$3.38$11.81K674,484
Gaurav Shah
CEO
Aug 13, 2026Sale−2,837$3.38$9.59K1,058,887
Sarbani Chaudhuri
See Remarks
Aug 11, 2026Sale−4,701$3.50$16.45K262,809
Christopher James Stevens
Chief Operating Officer
Aug 11, 2026Sale−36,658$3.50$128.30K505,784
Christopher James Stevens
Chief Operating Officer
Aug 3, 2026Award+73,313––542,442
David P. Southwell
Director
Aug 3, 2026Other+150,000––204,522
Mikael Dolsten
Director
Jun 18, 2026Award+22,862––67,082
Carsten Boess
Director
Jun 18, 2026Award+22,862––52,862
David P. Southwell
Director
Jun 18, 2026Award+22,862––54,522
Fady Ibraham Malik
Director
Jun 18, 2026Award+22,862––52,862
Peter Fong
Director
Jun 18, 2026Award+22,862––76,195
Roderick Wong
Director, 10% owner
Jun 18, 2026Award+27,832––75,499
Gaurav Shah
CEO
May 21, 2026Option exercise+76,490$1.69$129.27K1,117,408
Gaurav Shah
CEO
May 21, 2026Sale−55,684$3.09$172.06K1,061,724
Gaurav Shah
CEO
May 19, 2026Sale−2,409$3.01$7.25K1,040,918
Martin Wilson
General Counsel
May 19, 2026Sale−662$3.01$1.99K677,977
John Militello
See Remarks
May 19, 2026Sale−384$3.01$1.16K89,780
John Militello
See Remarks
May 13, 2026Sale−855$3.61$3.09K90,164
Gaurav Shah
CEO
May 13, 2026Sale−2,728$3.61$9.85K1,043,327
Martin Wilson
General Counsel
May 13, 2026Sale−3,361$3.61$12.13K678,639
Sarbani Chaudhuri
See Remarks
May 7, 2026Sale−17,650$3.84$67.78K267,510
Martin Wilson
General Counsel
Feb 18, 2026Sale−1,376$3.34$4.60K682,000
John Militello
See Remarks
Feb 18, 2026Sale−1,157$3.34$3.86K91,019
Gaurav Shah
CEO
Feb 18, 2026Sale−5,990$3.34$20.01K1,046,055
Martin Wilson
General Counsel
Feb 13, 2026Sale−12,253$3.31$40.56K683,376
John Militello
See Remarks
Feb 13, 2026Sale−3,726$3.31$12.33K92,176
Gaurav Shah
CEO
Feb 13, 2026Sale−12,279$3.31$40.64K1,052,045
Gaurav Shah
CEO
Feb 11, 2026Award+286,028––1,064,324
Martin Wilson
General Counsel
Feb 11, 2026Award+311,813––695,629
Syed Ali-aamir Rizvi
Chief Medical Officer
Feb 11, 2026Award+61,963––407,874
Christopher James Stevens
Chief Operating Officer
Feb 11, 2026Award+61,963––469,129
John Militello
See Remarks
Feb 11, 2026Award+29,982––95,902
Sarbani Chaudhuri
See Remarks
Feb 11, 2026Award+125,924––285,160
Elisabeth Bjork
Director
Jan 2, 2026Buy+10,000$3.44$34.40K50,000
Jonathan David Schwartz
See Remarks
Nov 18, 2025Sale−2,545$2.98$7.58K299,064
John Militello
See Remarks
Nov 18, 2025Sale−1,086$2.98$3.24K65,920
Gaurav Shah
CEO, Director
Nov 18, 2025Sale−6,276$2.98$18.70K778,296
Martin Wilson
General Counsel
Nov 18, 2025Sale−1,646$2.98$4.91K383,816
Martin Wilson
General Counsel
Nov 3, 2025Award+100,000––385,462
John Militello
See Remarks
Oct 14, 2025Sale−5,514$3.97$21.89K70,569
John Militello
See Remarks
Oct 14, 2025Sale−3,005$3.97$11.93K67,564
John Militello
See Remarks
Oct 14, 2025Sale−558$3.98$2.22K67,006
John Militello
See Remarks
Oct 14, 2025Sale−19,841$3.96$78.57K76,083
Syed Ali-aamir Rizvi
Chief Medical Officer
Oct 6, 2025Award+283,018––283,018
Syed Ali-aamir Rizvi
Chief Medical Officer
Oct 6, 2025Award+62,893––345,911
Peter Fong
Director
Sep 24, 2025Award+30,000––53,333
Peter Fong
Director
Sep 24, 2025Award+23,333––23,333
Rtw Investments, Lp
Director, 10% owner
Sep 19, 2025Option exercise+59,000$17.81$1.05M18,247,457
Rtw Investments, Lp
Director, 10% owner
Sep 19, 2025Other−41,000$3.11$127.51K18,188,457
Rtw Investments, Lp
Director, 10% owner
Sep 19, 2025Option exercise+41,000$19.09$782.69K18,229,457
Rtw Investments, Lp
Director, 10% owner
Sep 19, 2025Other−1,000,000$3.11$3.11M18,188,457
Rtw Investments, Lp
Director, 10% owner
Sep 19, 2025Option exercise+1,000,000$40.03$40.03M19,188,457
Rtw Investments, Lp
Director, 10% owner
Sep 19, 2025Other−59,000$3.11$183.49K18,188,457

Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.

Short interest

Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)

Short % of float
19.04%
16M shares short
Days to cover
9.1
At 2M shares a day
Change since last report
-0.2%
From 16M shares
Short volume, 20 days
53.7%
Of volume reported to FINRA

Shares sold short, last 12 months

Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Rocket Pharmaceuticals's stock actually held short. Settlement fails (shares not delivered on time) peaked at 28,613 shares on Aug 31, 2026 over the last 90 days.

Planned insider sales

Notices of proposed sale filed on Form 144 before shares are sold

SellerFiledSharesMarket valuePlanned saleAcquired through
Christopher James Stevens
Officer
Nov 9, 202616,131$37.53KNov 9, 2026Restricted Stock Vesting
Sarbani Chaudhuri
Officer
Nov 9, 20264,872$11.34KNov 9, 2026Restricted Stock Vesting
Martin Wilson
Officer
Nov 5, 202653,389$127.81KNov 5, 2026Restricted Stock Vesting
John Militello
Former Officer
Sep 15, 20266,897$22.73KSep 15, 2026Restricted Stock Vesting
John Militello
Former Officer
Sep 14, 20266,857$22.73KSep 14, 2026Restricted Stock Vesting
Martin Wilson
Officer
Sep 11, 202675,364$256.49KSep 11, 2026Restricted Stock Vesting
John Militello
Former Officer
Sep 11, 20268,923$30.37KSep 11, 2026Restricted Stock Vesting
John Militello
Former Officer
Aug 18, 20261,252$4.23KAug 18, 2026Restricted Stock Vesting
Martin Wilson
Officer
Aug 18, 2026631$2.13KAug 18, 2026Restricted Stock Vesting
Gaurav Shah
Officer, Director
Aug 18, 20262,293$7.75KAug 18, 2026Restricted Stock Vesting
Martin Wilson
Officer
Aug 13, 20263,493$11.81KAug 13, 2026Restricted Stock Vesting
Gaurav Shah
Officer, Director
Aug 13, 20262,837$9.59KAug 13, 2026Restricted Stock Vesting
Sarbani Chaudhuri
Officer
Aug 11, 20264,701$16.45KAug 11, 2026Restricted Stock Vesting
Christopher James Stevens
Officer
Aug 11, 202636,658$128.28KAug 11, 2026Restricted Stock Vesting
Fady Ibraham Malik
Director
Jul 7, 202610,670$41.39KJul 7, 2026Restricted Stock Vesting

See a number that looks wrong?